260 related articles for article (PubMed ID: 12151125)
1. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models.
Pitkänen A
Epilepsy Res; 2002 Jun; 50(1-2):141-60. PubMed ID: 12151125
[TBL] [Abstract][Full Text] [Related]
2. Drug-mediated neuroprotection and antiepileptogenesis: animal data.
Pitkänen A
Neurology; 2002 Nov; 59(9 Suppl 5):S27-33. PubMed ID: 12428029
[TBL] [Abstract][Full Text] [Related]
3. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
Löscher W
Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
[TBL] [Abstract][Full Text] [Related]
4. New pharmacotherapy for epilepsy.
Pitkanen A
IDrugs; 2004 May; 7(5):471-7. PubMed ID: 15154109
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam.
Klitgaard H; Pitkänen A
Epileptic Disord; 2003 May; 5 Suppl 1():S9-16. PubMed ID: 12915336
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic drugs to prevent neural degeneration associated with epilepsy: assessing the prospects for neuroprotection.
Sutula T
Epilepsy Res; 2002 Jun; 50(1-2):125-9. PubMed ID: 12151123
[No Abstract] [Full Text] [Related]
7. Antiepileptic drugs in neuroprotection.
Pitkänen A; Kubova H
Expert Opin Pharmacother; 2004 Apr; 5(4):777-98. PubMed ID: 15102563
[TBL] [Abstract][Full Text] [Related]
8. Anti-Epileptogenic Effects of Antiepileptic Drugs.
Miziak B; Konarzewska A; Ułamek-Kozioł M; Dudra-Jastrzębska M; Pluta R; Czuczwar SJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231010
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drugs and neuroprotection: current status and future roles.
Willmore LJ
Epilepsy Behav; 2005 Dec; 7 Suppl 3():S25-8. PubMed ID: 16239127
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection and epilepsy.
Halász P; Rásonyi G
Adv Exp Med Biol; 2004; 541():91-109. PubMed ID: 14977210
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective agents and modulation of temporal lobe epilepsy.
Fernandes MJ; Carneiro JE; Amorim RP; Araujo MG; Nehlig A
Front Biosci (Elite Ed); 2015 Jan; 7(1):79-93. PubMed ID: 25553365
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of epilepsy].
Legido A
Rev Neurol; 2002 Jan 16-31; 34(2):186-95. PubMed ID: 11988916
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
14. Disease modification in partial epilepsy.
Walker MC; White HS; Sander JW
Brain; 2002 Sep; 125(Pt 9):1937-50. PubMed ID: 12183340
[TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABA(A) receptor ligand binding in a model of temporal lobe epilepsy.
Volk HA; Arabadzisz D; Fritschy JM; Brandt C; Bethmann K; Löscher W
Neurobiol Dis; 2006 Mar; 21(3):633-46. PubMed ID: 16256358
[TBL] [Abstract][Full Text] [Related]
16. The multimodal prospects for neuroprotection and disease modification in epilepsy: relationship to its challenging neurobiology.
Hamed SA
Restor Neurol Neurosci; 2010; 28(3):323-48. PubMed ID: 20479527
[TBL] [Abstract][Full Text] [Related]
17. Anti-seizure medications and estradiol for neuroprotection in epilepsy: the 2013 update.
Velisek L; Nebieridze N; Chachua T; Veliskova J
Recent Pat CNS Drug Discov; 2013 Apr; 8(1):24-41. PubMed ID: 23477307
[TBL] [Abstract][Full Text] [Related]
18. Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy.
de Araujo Furtado M; Rossetti F; Chanda S; Yourick D
Neurotoxicology; 2012 Dec; 33(6):1476-1490. PubMed ID: 23000013
[TBL] [Abstract][Full Text] [Related]
19. Enlightening the neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities.
Akyuz E; Paudel YN; Polat AK; Dundar HE; Angelopoulou E
Epilepsy Behav; 2021 Feb; 115():107701. PubMed ID: 33412369
[TBL] [Abstract][Full Text] [Related]
20. Models in research of pharmacoresistant epilepsy: present and future in development of antiepileptic drugs.
Kovács R; Heinemann U
Curr Med Chem; 2014; 21(6):689-703. PubMed ID: 24251565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
